Publication:
Metallo-β-lactamase-producing Pseudomonas aeruginosa Isolates from Two Tertiary Care Centres in a District of Nepal: A Descriptive Cross-sectional Study

creativeworkseries.issnJNMA Print ISSN: 0028-2715; Online ISSN: 1815-672X
dc.contributor.authorShrestha, Pushpa Man
dc.contributor.authorKattel, Hari Prasad
dc.contributor.authorSharma, Sangita
dc.contributor.authorBista, Pratibha
dc.contributor.authorBasnet, Bhupendra Kumar
dc.contributor.authorGhimire, Prakash
dc.contributor.authorRijal, Komal Raj
dc.date.accessioned2025-08-15T07:00:41Z
dc.date.available2025-08-15T07:00:41Z
dc.date.issued2024
dc.descriptionPushpa Man Shrestha Tribhuvan University, Kirtipur, Kathmandu, Nepal. Hari Prasad Kattel Maharajgunj Medical Campus, Maharajgunj, Kathmandu, Nepal. Sangita Sharma Maharajgunj Medical Campus, Maharajgunj, Kathmandu, Nepal. Pratibha Bista National Academy of Medical Sciences, Bir Hospital, Mahabaudha, Kathmandu, Nepal. Bhupendra Kumar Basnet National Academy of Medical Sciences, Bir Hospital, Mahabaudha, Kathmandu, Nepal. Prakash Ghimire Tribhuvan University, Kirtipur, Kathmandu, Nepal. Komal Raj Rijal Tribhuvan University, Kirtipur, Kathmandu, Nepal.
dc.description.abstractAbstract Introduction: Pseudomonas aeruginosa isolates producing metallo-β-lactamase have caused nosocomial outbreaks, severe infections, and ineffective carbapenem therapy worldwide since 1991. Due to their prevalence, hospital infection control techniques are difficult. This study aimed to find out the prevalence of metallo-β-lactamase among P. aeruginosa isolates from two tertiary care hospitals in Kathmandu. Methods: A descriptive cross-sectional study was conducted at the Department of Microbiology and Department of Pathology of two tertiary care centres in Kathmandu from 7 December 2021 to 6 April 2023, after receiving ethical approval from the Ethical Review Board. Isolated strains were identified and tested for antibiotic susceptibility by modified Kirby-Bauer Methods. Metallo-β-lactamase presence was confirmed using an imipenem-imipenem/ ethylenediaminetetraacetic acid disc. A convenience sampling method was used. The point estimate was calculated at 95% Confidence Interval. Results: Among 255, Pseudomanas aeruginosa isolates, the distribution of metallo-β-lactamase-producing Pseudomanas aeruginosa was 103 (40.39%) (34.32-46.69 at 95% Confidence Interval). Multidrug resistance categories included multidrug resistance 74 (71.80%), extensively drug resistance 32 (31.10%), P. aeruginosa difficult-to-treat 16 (15.53%) and carbapenem-resistant P. aeruginosa was determined to be 82 (79.60%). Conclusions: The study found a high prevalence of metallo-β-lactamase-producing Pseudomanas aeruginosa isolates, requiring early identification, infection control measures, and an all-inclusive antimicrobial therapy protocol to reduce their spread in medical settings.
dc.identifierhttps://doi.org/10.31729/jnma.8498
dc.identifier.urihttps://hdl.handle.net/20.500.14572/1587
dc.language.isoen_US
dc.publisherNepal Medical Association
dc.titleMetallo-β-lactamase-producing Pseudomonas aeruginosa Isolates from Two Tertiary Care Centres in a District of Nepal: A Descriptive Cross-sectional Study
dc.typeArticle
dspace.entity.typePublication
local.article.typeOriginal Article
oaire.citation.endPage206
oaire.citation.startPage202
relation.isJournalIssueOfPublication882a8deb-2c2f-48c7-af2a-de99580c8f51
relation.isJournalIssueOfPublication.latestForDiscovery882a8deb-2c2f-48c7-af2a-de99580c8f51
relation.isJournalOfPublicatione6e146a0-0ece-4aba-aa0a-6ccfbd10a12a

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
202-206.pdf
Size:
338.96 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.86 KB
Format:
Item-specific license agreed to upon submission
Description:

Collections